Cypress Capital Group Johnson & Johnson Transaction History

Cypress Capital Group

$879 Million
Q3 2024

A detailed history of Cypress Capital Group transactions in Johnson & Johnson stock. As of the latest transaction made, Cypress Capital Group holds 78,429 shares of JNJ stock, worth $12.2 Million. This represents 1.45% of its overall portfolio holdings.

Number of Shares

78,429

Previous 80,263 2.28%

Holding current value

$12.2 Million

Previous $11.7 Million 8.35%

% of portfolio

1.45%

Previous 1.42%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$145.48 - $167.38 $266,810 - $306,974	-1,834 Reduced 2.28%	78,429 $12.7 Million
Q2 2024 Jul 25, 2024	SELL	$144.38 - $157.78 $152,032 - $166,142	-1,053 Reduced 1.29%	80,263 $11.7 Million
Q1 2024 May 08, 2024	BUY	$155.22 - $162.74 $199,147 - $208,795	1,283 Added 1.6%	81,316 $12.9 Million
Q4 2023 Jan 24, 2024	SELL	$145.6 - $158.88 $9,755 - $10,644	-67 Reduced 0.08%	80,033 $12.5 Million
Q3 2023 Nov 02, 2023	SELL	$155.75 - $174.48 $318,820 - $357,160	-2,047 Reduced 2.49%	80,100 $12.5 Million
Q2 2023 Jul 26, 2023	SELL	$154.35 - $166.11 $1.01 Million - $1.09 Million	-6,553 Reduced 7.39%	82,147 $13.6 Million
Q1 2023 May 04, 2023	SELL	$151.05 - $180.26 $440,461 - $525,638	-2,916 Reduced 3.18%	88,700 $13.7 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $149,466 - $167,744	-933 Reduced 1.01%	91,616 $16.2 Million
Q3 2022 Nov 04, 2022	SELL	$161.33 - $179.52 $753,572 - $838,537	-4,671 Reduced 4.8%	92,549 $15.1 Million
Q2 2022 Jul 26, 2022	SELL	$168.19 - $186.01 $48,270 - $53,384	-287 Reduced 0.29%	97,220 $17.3 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $1.65 Million - $1.87 Million	10,426 Added 11.97%	97,507 $17.3 Million
Q4 2021 Feb 15, 2022	SELL	$155.93 - $173.01 $288,470 - $320,068	-1,850 Reduced 2.08%	87,081 $14.9 Million
Q3 2021 Oct 12, 2021	SELL	$161.5 - $179.47 $289,408 - $321,610	-1,792 Reduced 1.98%	88,931 $14.4 Million
Q2 2021 Jul 13, 2021	BUY	$159.48 - $171.07 $118,653 - $127,276	744 Added 0.83%	90,723 $14.9 Million
Q1 2021 Apr 14, 2021	BUY	$153.07 - $170.48 $283,485 - $315,728	1,852 Added 2.1%	89,979 $14.8 Million
Q4 2020 Jan 12, 2021	SELL	$137.11 - $157.38 $278,333 - $319,481	-2,030 Reduced 2.25%	88,127 $13.9 Million
Q3 2020 Oct 08, 2020	BUY	$140.38 - $153.83 $1.16 Million - $1.28 Million	8,297 Added 10.14%	90,157 $13.4 Million
Q2 2020 Jul 10, 2020	SELL	$128.81 - $155.51 $3,606 - $4,354	-28 Reduced 0.03%	81,860 $11.5 Million
Q1 2020 Apr 08, 2020	SELL	$111.14 - $153.99 $66,239 - $91,778	-596 Reduced 0.72%	81,888 $10.7 Million
Q4 2019 Jan 10, 2020	SELL	$127.5 - $146.44 $311,992 - $358,338	-2,447 Reduced 2.88%	82,484 $12 Million
Q3 2019 Oct 10, 2019	SELL	$126.95 - $142.14 $1.47 Million - $1.65 Million	-11,593 Reduced 12.01%	84,931 $11 Million
Q2 2019 Aug 15, 2019	BUY	$131.15 - $144.24 $675,029 - $742,403	5,147 Added 5.63%	96,524 $13.4 Million
Q1 2019 May 14, 2019	BUY	$125.72 - $139.79 $105,479 - $117,283	839 Added 0.93%	91,377 $12.8 Million
Q4 2018 Feb 19, 2019	BUY	$122.84 - $147.84 $538,162 - $647,687	4,381 Added 5.08%	90,538 $11.7 Million
Q3 2018 Nov 15, 2018	BUY	$121.58 - $142.88 $40,486 - $47,579	333 Added 0.39%	86,157 $11.9 Million
Q2 2018 Aug 15, 2018	SELL	$119.4 - $131.76 $903,858 - $997,423	-7,570 Reduced 8.11%	85,824 $10.4 Million
Q1 2018 May 21, 2018	SELL	$125.1 - $148.14 $151,871 - $179,841	-1,214 Reduced 1.28%	93,394 $12 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $591,277 - $647,151	-4,506 Reduced 4.55%	94,608 $13.2 Million
Q3 2017 Nov 16, 2017	BUY	$129.47 - $135.38 $241,849 - $252,889	1,868 Added 1.92%	99,114 $12.9 Million
Q2 2017 Aug 15, 2017	BUY	N/A	97,246	97,246 $12.9 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Group with notifications on news.

Account

Cypress Capital Group Johnson & Johnson Transaction History